Crucial roles for protein kinase C isoforms in tumor-specific killing by apoptin

Cancer Research

Volumn 70, Issue 18, 2010, Pages 7242-7252

  Jiang, Jie ^a   Cole, Daryl ^b   Westwood, Nigel ^a   Macpherson, Lee ^a   Farzaneh, Farzin ^a   Mufti, Ghulam ^a   Tavassoli, Mahvash ^b   Gäken, Joop ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTIN; CASPASE 3; CASPASE 9; PROTEIN KINASE B; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN MERTK; PROTEIN TYROSINE KINASE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; CAPSID PROTEIN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PROTEIN KINASE C; SMALL INTERFERING RNA; VP3 PROTEIN, CHICKEN ANEMIA VIRUS;

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; GENE VECTOR; GENETICS; HCT116 CELL LINE; HL 60 CELL LINE; K562 CELL LINE; LENTIVIRINAE; LEUKEMIA; METABOLISM; PHOSPHORYLATION; U937 CELL LINE;

CAPSID PROTEINS; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HCT116 CELLS; HL-60 CELLS; HUMANS; K562 CELLS; LENTIVIRUS; LEUKEMIA; MULTIPLE MYELOMA; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C BETA; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; U937 CELLS;

EID: 77956913167     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-1204     Document Type: Article

References (49)

1. Clark RE, Grzybowski J, Broughton CM, et al. Clinical use of streptolysin-O to facilitate antisense oligodeoxyribonucleotide delivery for purging autografts in chronic myeloid leukaemia. Bone Marrow Transplant 1999;23:1303-8.
2. Dilber MS, Gahrton G. Suicide gene therapy: possible applications in haematopoietic disorders. J Intern Med 2001;249:359-67.
3. Thirukkumaran CM, Russell JA, Stewart DA, Morris DG. Viral purging of haematological autografts: should we sneeze on the graft? Bone Marrow Transplant 2007;40:1-12.
4. + peripheral blood stem cells: retained engraftment capability and reduced tumor cell content. Br J Haematol 1999;104:382-91.
5. Visani G, Dinota A, Tosi P, et al. Cryopreserved autologous bone marrow transplantation in patients with acute nonlymphoid leukemia: chemotherapy before harvesting is the main factor in delaying hematological recovery. Cryobiology 1990;27:103-6.
6. + hematopoietic progenitor cells for transplantation. Stem Cells 1993;11 Suppl 3:48-9.
7. + cells. J Transl Med 2007;5:35.
8. Mendoza-Maldonado R, Zentilin L, Fanin R, Giacca M. Purging of chronic myelogenous leukemia cells by retrovirally expressed antibcr- abl ribozymes with specific cellular compartmentalization. Cancer Gene Ther 2002;9:71-86.
9. Noteborn MH. Proteins selectively killing tumor cells. Eur J Pharmacol 2009;625:165-73.
10. Tavassoli M, Guelen L, Luxon BA, Gaken J. Apoptin: specific killer of tumor cells? Apoptosis 2005;10:717-24.
11. Danen-van Oorschot AA, Fischer DF, Grimbergen JM, et al. Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci U S A 1997;94:5843-7.
12. Danen-van Oorschot AA, van der Eb AJ, Noteborn MH. The chicken anemia virus-derived protein apoptin requires activation of caspases for induction of apoptosis in human tumor cells. J Virol 2000;74:7072-8.
13. Guelen L, Paterson H, Gaken J, et al. TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells. Oncogene 2004;23:1153-65.
14. Danen-van Oorschot AA, Zhang YH, Leliveld SR, et al. Importance of nuclear localization of apoptin for tumor-specific induction of apoptosis. J Biol Chem 2003;278:27729-36.
15. Heilman DW, Teodoro JG, Green MR. Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization, apoptosis, and recruitment of the anaphase-promoting complex/cyclosome to PML bodies. J Virol 2006;80:7535-45.
16. Lee YH, Cheng CM, Chang YF, Wang TY, Yuo CY. Apoptin T108 phosphorylation is not required for its tumor-specific nuclear localization but partially affects its apoptotic activity. Biochem Biophys Res Commun 2007;354:391-5.
17. Zhang YH, Kooistra K, Pietersen A, Rohn JL, Noteborn MH. Activation of the tumor-specific death effector apoptin and its kinase by an N-terminal determinant of simian virus 40 large T antigen. J Virol 2004;78:9965-76.
18. Maddika S, Wiechec E, Ande SR, et al. Interaction with PI3-kinase contributes to the cytotoxic activity of apoptin. Oncogene 2008;27:3060-5.
19. Maddika S, Panigrahi S, Wiechec E, et al. Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity. Mol Cell Biol 2009;29:1235-48.
20. Martelli AM, Faenza I, Billi AM, et al. Nuclear protein kinase C isoforms: key players in multiple cell functions? Histol Histopathol 2003;18:1301-12.
21. Neri LM, Borgatti P, Capitani S, Martelli AM. Protein kinase C isoforms and lipid second messengers: a critical nuclear partnership? Histol Histopathol 2002;17:1311-6.
22. Redig AJ, Platanias LC. The protein kinase C (PKC) family of proteins in cytokine signaling in hematopoiesis. J Interferon Cytokine Res 2007;27:623-36.
23. Martelli AM, Evangelisti C, Nyakern M, Manzoli FA. Nuclear protein kinase C. Biochim Biophys Acta 2006;1761:542-51.
24. Assender JW, Gee JM, Lewis I, et al. Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer. J Clin Pathol 2007;60:1216-21.
25. Komada F, Nishikawa M, Uemura Y, et al. Expression of three major protein kinase C isozymes in various types of human leukemic cells. Cancer Res 1991;51:4271-8.
26. Reyland ME. Protein kinase C isoforms: multi-functional regulators of cell life and death. Front Biosci 2009;14:2386-99.
27. Chan L, Nesbeth D, Mackey T, et al. Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells. J Virol 2005;79:13190-4.
28. Huang Y, Kong WP, Nabel GJ. Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. J Virol 2001;75:4947-51.
29. Layne SP, Merges MJ, Dembo M, et al. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 1992;189:695-714.
30. Newton AC. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 2001;101:2353-64.
31. Poon IK, Oro C, Dias MM, Zhang J, Jans DA. Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells. Cancer Res 2005;65:7059-64.
32. Rohn JL, Zhang YH, Aalbers RI, et al. A tumor-specific kinase activity regulates the viral death protein Apoptin. J Biol Chem 2002;277:50820-7.
33. Kuusisto HV, Wagstaff KM, Alvisi G, Jans DA. The C-terminus of apoptin represents a unique tumor cell-enhanced nuclear targeting module. Int J Cancer 2008;123:2965-9.
34. Alvisi G, Poon IK, Jans DA. Tumor-specific nuclear targeting: promises for anti-cancer therapy? Drug Resist Updat 2006;9:40-50.
35. Ludwig S, Pleschka S, Planz O, Wolff T. Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell Microbiol 2006;8:375-86.
36. Mitzner D, Dudek SE, Studtrucker N, et al. Phosphorylation of the influenza A virus protein PB1-2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell Microbiol 2009;11:1502-16.
37. Reinhardt J, Wolff T. The influenza A virus M1 protein interacts with the cellular receptor of activated C kinase (RACK) 1 and can be phosphorylated by protein kinase C. Vet Microbiol 2000;74:87-100.
38. Los M, Panigrahi S, Rashedi I, et al. Apoptin, a tumor-selective killer. Biochim Biophys Acta 2009;1793:1335-42.
39. Janicke RU. MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Treat 2009;117:219-21.
40. Bachelder RE, Wendt MA, Fujita N, Tsuruo T, Mercurio AM. The cleavage of Akt/protein kinase B by death receptor signaling is an important event in detachment-induced apoptosis. J Biol Chem 2001;276:34702-7.
41. Xu J, Liu D, Songyang Z. The role of Asp-462 in regulating Akt activity. J Biol Chem 2002;277:35561-6.
42. Chou CC, Hsu CY. Involvement of PKC in TPA-potentiated apoptosis induction during hemin-mediated erythroid differentiation in K562 cells. Naunyn Schmiedebergs Arch Pharmacol 2009;379:1-9.
43. Meinhardt G, Roth J, Hass R. Activation of protein kinase C relays distinct signaling pathways in the same cell type: differentiation and caspase-mediated apoptosis. Cell Death Differ 2000;7:795-803.
44. Meinhardt G, Eppinger E, Schmidmaier R. Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells. Anticancer Drugs 2002;13:725-33.
45. Kurokawa M, Kornbluth S. Caspases and kinases in a death grip. Cell 2009;138:838-54.
46. Yin XM. Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 2006;369:7-19.
47. Martelli AM, Mazzotti G, Capitani S. Nuclear protein kinase C isoforms and apoptosis. Eur J Histochem 2004;48:89-94.
48. Brodie C, Blumberg PM. Regulation of cell apoptosis by protein kinase Cδ. Apoptosis 2003;8:19-27.
49. Fulda S. Cell death in hematological tumors. Apoptosis 2009;14:409-23.